We are developing a life technology platform called BioEngine4D℠ to digitally detect developing diseases by aggregating this "big data" of life, analyzing it through computational advancements in machine learning and artificial intelligence, and applying it back to life.
We so often think of Healthcare as an industry that we tend to forget about Healthcare as a purpose.
BioTrillion believes that purpose is to optimize quality of life and longevity. We also believe solutions can be reframed through the individual’s perspective into 3 key phases: “Prevention,” “Detection,” and “Intervention” of health disorders and diseases. We are focused on Detection, with the Prevention and Intervention phases as our adjacencies.
We spend less than 1% of our time in a Health setting and expect the health data generated there to lead to enhanced outcomes. Health data is abundant, but it is also siloed, unstructured, and intermittent. As a result, a massive amount of it is not being adequately connected to our health. Health settings offer access to tremendous medical experience and clinically-validated diagnostics; however, its utility will be fundamentally limited if the typical Consumer only spends < 1% of their total time in an actual Health setting.
The Life setting provides access to something the Health setting does not — that other 99% of time. It is during this massive gap in time where the signs of developing diseases may be expressed, but go undetected, creating both clinical and economic opportunities in the market for objective, passive, and continuous solutions. We believe solutions will come from outside the Health setting, from within the Life setting, with the addition of LIFEdata℠, which we define as sensor-measured information generated from life and around life.
Our goal is to empower people with access to better healthcare — before becoming patients — by shifting disease detection earlier in the healthcare continuum, from developed to developing. Advances in technology have amplified our individual capabilities in many ways, and better caring for our own health should be no exception.
Today, life information is exponentially transitioning out of an analog world and into a digital one. An increasing number of sensors in our smart devices are entering our Life setting and have the ability to capture many earlier signs of disease in the form of LIFEdata through multiple modalities. These sensors are often disparate and thus limited in perspective when analyzed alone, yet are synergistic in value when analyzed interconnectedly.
BioTrillion is focused on aggregating the LIFEdata from these sensors with existing quantified health data, and training BioEngine4D through machine learning and artificial intelligence to statistically and digitally detect developing diseases and disorders. BioEngine4D is being developed as a much-needed accessible, objective, passive, and continuous health technology to help bridge the gap between the Healthcare and Home settings.
Novel technologies that have been synergistically applied to traditional domains have yielded entirely new possibilities to solve old problems in new ways. We see an inflection point in the future where the health value of data generated in the Life setting will exceed that of data generated in the Health setting. And where Health solutions will be oriented around accessibility, timeliness, and quantitatively enhanced outcomes. Solutions that — in retrospect — will make us realize that our health had been "in the dark" 99% of the time.
We believe that data from life should be data for life.
More about BioEngine4D
BioTrillion, Inc. was formed in December 2017 and is headquartered in San Francisco, CA. Our corporate counsel is Latham and Watkins. We are reimagining Life Sciences through the principles of many sciences.
In our first year: